Polymer Free Amphilimus Drug Eluting Stent for Infrapopliteal Arterial Disease in Patients with Critical Limb Ischemia: A New Device in the Armamentarium

Polymer Free Amphilimus Drug Eluting Stent for Infrapopliteal Arterial Disease in Patients with Critical Limb Ischemia: A New Device in the Armamentarium

<b><i>Background and Objectives</i>:</b> Endovascular technologies have significantly improved the outcome of patients with critical limb ischemia (CLI). Drug eluting stents (DES) have documented their efficacy against percutaneous transluminal angioplasty (PTA) and bare meta...

Full description

Bibliographic Details
Main Authors:	Konstantinos Tigkiropoulos, Manolis Abatzis-Papadopoulos, Katerina Sidiropoulou, Kyriakos Stavridis, Dimitrios Karamanos, Ioannis Lazaridis, Nikolaos Saratzis
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	Medicina
Subjects:	critical limb ischemia below the knee drug eluting stents Cre8 polymer free endovascular
Online Access:	https://www.mdpi.com/1648-9144/59/1/39

Similar Items

One-year outcomes following primary stenting of infrapopliteal steno-occlusive arterial disease using a non-polymer sirolimus-eluting stent: Results from a prospective single-centre cohort study
by: Konstantinos Tigkiropoulos, et al.
Published: (2022-10-01)

Current Status of and Future Prospects for Drug-Eluting Stents and Scaffolds in Infrapopliteal Arteries
by: Elizabeth Lim, et al.
Published: (2024-03-01)

Long‐Term Follow‐up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug‐Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia
by: Marlon I. Spreen, et al.
Published: (2017-04-01)

Below Knee Angioplasty Using Drug-Eluting Balloons in Patients with Critical Limb Ischemia with Six Months Follow-Up: Single-Center Experience at Tertiary Care Hospital
by: Jawahar Rathod, et al.
Published: (2022-12-01)

Comparison of the long-term results of bypass surgery versus below-the-knee angioplasty in infrapopliteal lesions that results in ulcer or toe gangrene
by: Mohammad Reza Kalantar Motamedi, et al.
Published: (2023-01-01)

One-Year Outcomes of CGuard Double Mesh Stent in Carotid Artery Disease: A Systematic Review and Meta-Analysis
by: Konstantinos Tigkiropoulos, et al.
Published: (2024-02-01)

Usefulness of off-label use of coronary drug-eluting stents as bailout for patients with critical limb ischemia and infrapopliteal arterial occlusive disease
by: Natarajan Sekar, et al.
Published: (2023-01-01)

Drug-Eluting Stents Versus Conventional Endovascular Therapies in Symptomatic Infrapopliteal Peripheral Artery Disease: A Meta-analysis
by: Khalid Changal, MD, et al.
Published: (2022-03-01)

One-year outcomes of polymer-free amphilimus-eluting stents versus durable polymer zotarolimus-eluting stents in patients with diabetes mellitus: a meta-analysis
by: Hong Wang, et al.
Published: (2022-10-01)

Cre8 Drug Eluting Stent Performance in Daily Cardiology Practice
by: Umit Yasar Sinan, et al.
Published: (2023-02-01)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01)

Role of infrapopliteal
by: Wael M. Wagdy, et al.
Published: (2016-09-01)

Aneurysmal degeneration of fluoropolymer-coated paclitaxel-eluting stent in the superficial femoral artery: a rising concern
by: Takuya Tsujimura, et al.
Published: (2021-07-01)

The efficacy and safety of different endovascular modalities for infrapopliteal arteries lesions: A network meta-analysis of randomized controlled trials
by: Julong Guo, et al.
Published: (2022-11-01)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
by: Iraj Jafaripour, et al.
Published: (2023-05-01)

Drug-eluting stents: long-term safety
by: Yu A Karpov, et al.
Published: (2009-05-01)

Ultrathin Strut Biodegradable Polymer Sirolimus‐Eluting Stent Versus Durable‐Polymer Everolimus‐Eluting Stent for Percutaneous Coronary Revascularization: 2‐Year Results of the BIOSCIENCE Trial
by: Rainer Zbinden, et al.
Published: (2016-03-01)

Comparison of 7-Year, Real-World Clinical Outcomes between Drug-Coated Balloon Angioplasty versus Drug-Eluting Stent Implantation in Patients with Drug-Eluting Stent In-Stent Restenosis
by: Minsu Kim, et al.
Published: (2023-06-01)

The Endovascular Armamentarium to Save the Dying Brain: Prospects and Challenges
by: Santhosh Poyyamoli, et al.
Published: (2017-04-01)

Sustained Antibiotic-Eluting Intra-Ocular Lenses: A New Approach
by: Tan, Dulcia Wei Ni, et al.
Published: (2017)

The Twelve-Month Outcome of Biolimus Eluting Stent with Biodegradable Polymer Compared With an Everolimus Eluting Stent with Durable Polymer
by: Ahmad Separham, et al.
Published: (2011-11-01)

Five-Year Comparative Efficacy of Everolimus-Eluting vs. Resolute Zotarolimus-Eluting Stents in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: Endrin Koni, et al.
Published: (2021-03-01)

Limb salvage following below-the-ankle angioplasty in critical limb ischemia
by: B Nishan, et al.
Published: (2020-01-01)

Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials
by: Lulu Liu, et al.
Published: (2018-03-01)

Mechanical rotational thrombectomy with Rotarex system augmented with drug-eluting balloon angioplasty vs. stenting for the treatment of acute thrombotic and critical limb ischaemia in the femoropopliteal segment
by: Paweł Latacz, et al.
Published: (2018-11-01)

Angiographic and Intravascular Imaging Findings for Ultrasound Detected Aneurysmal Degeneration Following Polymer Based Paclitaxel Eluting Nitinol Stent Implantation for Femoropopliteal Artery Occlusion
by: Tatsuya Nakama, et al.
Published: (2020-01-01)

Triple-vessel coronary artery aneurysms following drug-eluting stents
by: Immaneni Sathyamurthy, et al.
Published: (2023-01-01)

Effect of a Drug-Eluting Stent vs. Bare Metal Stent for the Treatment of Symptomatic Intracranial and Vertebral Artery Stenosis
by: Jiang-Hua Si, et al.
Published: (2022-07-01)

Laser Microperforation Assisted Drug-Elution from Biodegradable Films
by: Arkady S. Abdurashitov, et al.
Published: (2022-10-01)

Comparison of clinical outcomes after drug-eluting balloon and drug-eluting stent use for in-stent restenosis related acute myocardial infarction: a retrospective study
by: Chih-Yuan Fang, et al.
Published: (2018-04-01)

An AnteOwl WR intravascular ultrasound-guided parallel wiring technique for chronic total occlusion of below-the-knee arteries
by: Naoki Hayakawa, et al.
Published: (2022-03-01)

Removal of antibodies from red cells: Comparison of three elution methods
by: Rahul Katharia, et al.
Published: (2013-01-01)

Drug-Eluting Stents and Balloons—Materials, Structure Designs, and Coating Techniques: A Review
by: I. Rykowska, et al.
Published: (2020-10-01)

Impact of Optimal Medical Therapy on Reintervention and Survival Rates after Endovascular Infrapopliteal Revascularization
by: Tim Wittig, et al.
Published: (2023-08-01)

Endovascular Treatment of Arterial Steno-Occlusive Lesions in Symptomatic Moyamoya Disease
by: Jae-Chan Ryu, et al.
Published: (2022-11-01)

Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?
by: Flavius-Alexandru Gherasie, et al.
Published: (2023-04-01)

12-Month clinical outcomes of amphilimus drug eluting stents in an all-comers South-East Asian registry
by: Hee Hwa Ho, et al.
Published: (2020-02-01)

Combined Treatment of Native Femoropopliteal Occlusions in Chronic Limb-Threatening Ischemia Using Atherectomy Debulking and a New Sirolimus Drug-Coated Balloon (SELUTION SLR)
by: Joseph Sumner, et al.

Oritavancin polymethylmethacrylate (PMMA)—compressive strength testing and in vitro elution
by: Suzannah M. Schmidt-Malan, et al.
Published: (2019-02-01)

Study of the alternative elution agent for the DIPHONIX resin
by: Kanka Lukas, et al.
Published: (2016-01-01)